Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas

Por Orlova, Anna, Wingelhofer, Bettina, Neubauer, Heidi A., Maurer, Barbara, Berger-Becvar, Angelika, Keserű, György Miklós, Gunning, Patrick T., Valent, Peter, Moriggl, Richard
Publicado no Expert Opin Ther Targets (2017)

Malignant Phenotypes in Metastatic Melanoma are Governed by SR-BI and its Association with Glycosylation and STAT5 Activation

Por Kinslechner, Katharina, Schörghofer, David, Schütz, Birgit, Vallianou, Maria, Wingelhofer, Bettina, Mikulits, Wolfgang, Röhrl, Clemens, Hengstschläger, Markus, Moriggl, Richard, Stangl, Herbert, Mikula, Mario
Publicado no Mol Cancer Res (2017)

The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma

Por Keller, Alexandra, Wingelhofer, Bettina, Peter, Barbara, Bauer, Karin, Berger, Daniela, Gamperl, Susanne, Reifinger, Martin, Cerny-Reiterer, Sabine, Moriggl, Richard, Willmann, Michael, Valent, Peter, Hadzijusufovic, Emir
Publicado no Vet Comp Oncol (2017)

Pharmacologic inhibition of STAT5 in acute myeloid leukemia

Por Wingelhofer, Bettina, Maurer, Barbara, Heyes, Elizabeth C., Cumaraswamy, Abbarna A., Berger-Becvar, Angelika, de Araujo, Elvin D., Orlova, Anna, Freund, Patricia, Ruge, Frank, Park, Jisung, Tin, Gary, Ahmar, Siawash, Lardeau, Charles-Hugues, Sadovnik, Irina, Bajusz, Dávid, Keserű, György Miklós, Grebien, Florian, Kubicek, Stefan, Valent, Peter, Gunning, Patrick T., Moriggl, Richard
Publicado no Leukemia (2018)